Israel vs South-East Asia (WHO region): Treatment success rate: XDR-TB cases
Israel
100
in 2022
South-East Asia (WHO region)
73
in 2022
Israel rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate: XDR-TB cases over time
- Israel
- South-East Asia (WHO region)
How they compare
Israel currently reports 100 against 73 in South-East Asia (WHO region), a difference of 27.
That makes Israel's figure about 1.4 times South-East Asia (WHO region)'s.
The two have swapped places 6 times across 11 shared years of data; in 2012 it was Israel ahead.
Israel ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
Across the 2 decades both report, Israel averaged higher in 1 and South-East Asia (WHO region) in 1.
Head to head by decade
| Decade | Israel | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.5 | 37 | 25.5 | Israel |
| 2020s | 60 | 69 | 9 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Israel or South-East Asia (WHO region)?
- Israel, at 100 against 73 in South-East Asia (WHO region) as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Israel and South-East Asia (WHO region)?
- 27, with Israel ahead.
- How many years of comparable data are there for Israel and South-East Asia (WHO region)?
- 11 years are reported by both, from 2012 to 2022.
- How do Israel and South-East Asia (WHO region) rank globally for treatment success rate: xdr-tb cases?
- Israel ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.